[HTML] mdpi.com

[HTML][HTML] A breath of fresh air in the fog of antimicrobial resistance: inhaled polymyxins for gram-negative pneumonia

M Biagi, D Butler, X Tan, S Qasmieh, E Wenzler - Antibiotics, 2019 - mdpi.com
Despite advancements in therapy, pneumonia remains the leading cause of death due to
infectious diseases. Novel treatment strategies are desperately needed to optimize the …
被引用次数：21 相关文章

A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia

M Biagi, D Butler, X Tan, S Qasmieh - Antibiotics, 2019 - search.proquest.com
Despite advancements in therapy, pneumonia remains the leading cause of death due to
infectious diseases. Novel treatment strategies are desperately needed to optimize the …

A breath of fresh air in the fog of antimicrobial resistance: inhaled polymyxins for Gram-negative pneumonia.

M Biagi, D Butler, TX Tan Xing, S Qasmieh, E Wenzler - 2019 - cabidigitallibrary.org
Despite advancements in therapy, pneumonia remains the leading cause of death due to
infectious diseases. Novel treatment strategies are desperately needed to optimize the …

A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia.

M Biagi, D Butler, X Tan, S Qasmieh… - Antibiotics (Basel …, 2019 - europepmc.org
Despite advancements in therapy, pneumonia remains the leading cause of death due to
infectious diseases. Novel treatment strategies are desperately needed to optimize the …

A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia.

M Biagi, D Butler, X Tan, S Qasmieh… - Antibiotics (2079 …, 2019 - search.ebscohost.com
Despite advancements in therapy, pneumonia remains the leading cause of death due to
infectious diseases. Novel treatment strategies are desperately needed to optimize the …
[HTML] nih.gov

[HTML][HTML] A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia

M Biagi, D Butler, X Tan, S Qasmieh, E Wenzler - Antibiotics, 2019 - ncbi.nlm.nih.gov
Despite advancements in therapy, pneumonia remains the leading cause of death due to
infectious diseases. Novel treatment strategies are desperately needed to optimize the …

A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia

M Biagi, D Butler, X Tan… - Antibiotics (Basel …, 2019 - pubmed.ncbi.nlm.nih.gov
Despite advancements in therapy, pneumonia remains the leading cause of death due to
infectious diseases. Novel treatment strategies are desperately needed to optimize the …
[PDF] semanticscholar.org

[PDF][PDF] A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia

M Biagi, D Butler, X Tan, S Qasmieh, E Wenzler - pdfs.semanticscholar.org
Despite advancements in therapy, pneumonia remains the leading cause of death due to
infectious diseases. Novel treatment strategies are desperately needed to optimize the …

A Breath of Fresh Air in the Fog of Antimicrobial Resistance: Inhaled Polymyxins for Gram-Negative Pneumonia.

M Biagi, D Butler, X Tan, S Qasmieh… - Antibiotics (Basel …, 2019 - europepmc.org
Despite advancements in therapy, pneumonia remains the leading cause of death due to
infectious diseases. Novel treatment strategies are desperately needed to optimize the …